LGP Flower THC 22 Desert Flame medical cannabis flower
Desert Flame is a value-focused premium flower grown in-house by Little Green Pharma, developed to make the brand’s own cultivation standards accessible to a broader range of prescribed patients. The cultivar delivers a warm, spiced and earthy aroma layered over subtle citrus notes, with well-formed buds that present consistently from batch to batch. As a value-focused product, Desert Flame sits at a more accessible price point than the flagship Bush Lantern, while still benefiting from the same in-house cultivation oversight, laboratory testing, and quality assurance processes that define the LGP brand.
This accessibility matters for patients managing ongoing prescriptions who need a reliable, cost-effective flower option without sacrificing the quality indicators they depend on. Little Green Pharma applies the same foundational cultivation standards to Desert Flame as it does across its broader in-house range, meaning patients can expect properly dried, tested, and sealed flower regardless of the price tier. For many patients, knowing their value-focused option comes from the same in-house LGP operation as the brand’s flagship strain is an important part of their confidence in this product.
Little Green Pharma positions Desert Flame as a core, regularly available offering within its value tier, designed to give patients consistent access as part of their ongoing treatment routine. Patients who use Desert Flame regularly can generally expect more reliable restocking than limited craft or boutique cultivars in the broader range.
THC percentage
Each batch of Desert Flame is tested by an independent laboratory, and the certificate of analysis reports total THC content specific to that harvest, targeting the cultivar’s signature 22 percent THC range. Patients should always refer to the batch-specific COA rather than the general percentage in the product name, since potency can vary slightly between harvests even within a well-maintained in-house genetic line.
Maintaining standardised in-house growing conditions helps Little Green Pharma keep THC output reasonably consistent for Desert Flame across its regular production cycles, supporting the cultivar’s role as a dependable, everyday option for patients who need a reliable potency baseline.
Patients managing their dosage closely should keep their COA on file and compare it against previous batches they have used, as this is the most accurate way to track potency changes and adjust dosing in consultation with their prescriber.
CBD percentage
Desert Flame is primarily cultivated as a THC-dominant cultivar, and its CBD content is generally modest and reported on each batch’s certificate of analysis. Even at lower concentrations, CBD contributes to the overall cannabinoid profile and may play a role in the entourage effect alongside THC and the cultivar’s terpenes.
Little Green Pharma’s quality team tests for CBD alongside THC on every batch to ensure the full cannabinoid picture is available to prescribing doctors and patients. This transparency allows patients to make informed decisions about whether this particular cannabinoid ratio suits their treatment goals.
Patients who require a more balanced or CBD-forward profile should discuss alternative cultivars in the Little Green Pharma range with their prescriber, as Desert Flame is best suited to those seeking a predominantly THC-driven effect.
Terpene profile
The defining feature of Desert Flame is its warm, spiced and earthy terpene expression, layered with subtle citrus brightness that gives the cultivar an approachable, distinctive character suited to everyday therapeutic use. Terpenes are responsible for both the aroma and much of the nuanced sensory experience of cannabis, and Little Green Pharma applies standardised drying and curing protocols to maintain this profile consistently across production runs.
Controlled drying and curing remain important for terpene retention at every price tier, since heat and rushed processing can degrade these compounds quickly regardless of cultivar. The in-house cultivation team manages humidity and temperature carefully during this stage to protect the aromatic profile patients have come to associate with Desert Flame.
Each batch’s terpene report, where available, is included alongside the cannabinoid COA so patients can see exactly which terpenes are present in their specific harvest, supporting a more informed approach to selecting flower.
Cultivar lineage
Desert Flame has been selected for its warm, spiced terpene character combined with reliable structural qualities such as well-formed bud structure and reasonable trichome coverage, traits that suit the cultivar’s role as a dependable, regularly available option within the LGP in-house range. Its lineage reflects a selection process favouring consistency and cultivar stability suited to frequent in-house production cycles.
Genetic stability is important for a value-focused cultivar produced across regular cycles, since it allows the in-house cultivation team to reproduce a recognisable phenotype batch after batch without the variability that can occur with less established genetics.
Patients who have used Desert Flame previously can have confidence that each new batch is grown from the same well-maintained genetic stock that underpins its position as a dependable, accessible LGP house cultivar.
Batch testing
Every batch of Desert Flame undergoes independent laboratory testing prior to release, covering cannabinoid potency, terpene content where applicable, and screening for contaminants such as microbials, heavy metals, and pesticide residues. This testing regime is a core part of Little Green Pharma’s quality assurance process and applies equally to value-focused cultivars like Desert Flame as to any other product in the range, ensuring that accessibility never comes at the expense of patient safety.
Results are documented in a certificate of analysis that is batch-specific, meaning the figures correspond exactly to the jar a patient receives rather than an average across multiple harvests. This level of traceability matters in a therapeutic context, where dosing accuracy directly affects patient outcomes.
Patients are encouraged to request or review their batch’s COA and raise any questions about testing results with their prescribing doctor or pharmacist before adjusting their usual dosing routine.
Moisture content
Moisture content is carefully monitored throughout drying and curing to ensure Desert Flame arrives at an optimal level for both safe storage and consistent inhalation performance. Flower that is too moist is prone to mould risk and uneven burning, while flower that is too dry can lose terpene content and become harsh.
Little Green Pharma applies standardised in-house drying schedules across Desert Flame production to ensure moisture content remains reasonably consistent from batch to batch, supporting a dependable inhalation experience patients can rely on at an accessible price point.
Proper storage after delivery, in a cool, dark, airtight environment, helps maintain the moisture balance achieved during processing, and patients are encouraged to keep flower in its original sealed packaging until ready for use.
Trim quality
Desert Flame undergoes a quality-controlled trimming process designed to maintain consistent bud presentation across regular in-house production runs. Little Green Pharma applies clear quality benchmarks to ensure excess leaf material is removed without significantly compromising trichome coverage, balancing efficiency with a reasonable standard of presentation suited to the value-focused tier.
This results in buds that are reasonably well presented and structurally consistent from batch to batch, supporting patient confidence in Desert Flame as a dependable everyday option within the LGP house range.
Maintaining this trim standard also supports consistent airflow during curing, helping protect the moisture balance and terpene retention discussed above across every production run.
Packaging freshness seal
Desert Flame is packaged in airtight, light-protective containers fitted with a tamper-evident freshness seal, designed to lock in aroma and protect against light degradation and moisture loss during transit and storage. This packaging standard is applied consistently across the Little Green Pharma range, including value-focused cultivars like Desert Flame, ensuring the flower arrives in the same condition it left the facility.
The seal also provides an additional layer of assurance for patients, confirming the product has not been opened or accessed between leaving the dispensing pharmacy and arriving at the patient’s door.
Patients should inspect the seal upon arrival and retain original packaging for storage to preserve freshness for as long as possible after opening.
Shipping, insurance, and delivery assurance
All orders are covered by insured freight, meaning the value of the shipment is protected in the event of loss or damage during transit, giving patients confidence that their prescribed treatment is financially safeguarded from dispatch to doorstep. Given the prescription nature of this product, deliveries require a signature on delivery, ensuring the package is received directly by the patient or an authorised recipient.
Before any order leaves the dispensing facility, it passes through pre-shipment quality checks, which confirm that packaging seals are intact, labelling is correct, and the product matches the prescription on file. This step exists specifically to catch any issues before they reach the patient.
In the rare event that an issue does occur, a clear damage claim process is available. Patients should photograph the affected packaging and product immediately upon receipt and contact customer support within the stated claim window so the matter can be assessed and resolved promptly.
To explore further value-focused, standard, and premium cultivars available for prescribed patients, browse the full dried flower collection at https://littlegreenpharma.shop/product-category/dried-flower-inhalation/



















Reviews
There are no reviews yet.